Alaunos Therapeutics Inc (TCRT)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Nov 04, 13:10
Alaunos Therapeutics Total Assets (Quarterly): 4.678M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.678M |
| March 31, 2024 | 6.037M |
| December 31, 2023 | 8.263M |
| September 30, 2023 | 19.44M |
| June 30, 2023 | 27.93M |
| March 31, 2023 | 48.64M |
| December 31, 2022 | 64.94M |
| September 30, 2022 | 67.34M |
| June 30, 2022 | 73.93M |
| March 31, 2022 | 84.99M |
| December 31, 2021 | 94.86M |
| September 30, 2021 | 113.76M |
| June 30, 2021 | 106.76M |
| March 31, 2021 | 128.47M |
| December 31, 2020 | 146.34M |
| September 30, 2020 | 165.89M |
| June 30, 2020 | 181.68M |
| March 31, 2020 | 198.28M |
| December 31, 2019 | 109.11M |
| September 30, 2019 | 117.95M |
| June 30, 2019 | 73.17M |
| March 31, 2019 | 83.50M |
| December 31, 2018 | 95.05M |
| September 30, 2018 | 66.80M |
| June 30, 2018 | 76.38M |
| Date | Value |
|---|---|
| March 31, 2018 | 87.46M |
| December 31, 2017 | 105.61M |
| September 30, 2017 | 116.56M |
| June 30, 2017 | 126.81M |
| March 31, 2017 | 94.49M |
| December 31, 2016 | 106.35M |
| September 30, 2016 | 117.12M |
| June 30, 2016 | 128.01M |
| March 31, 2016 | 141.68M |
| December 31, 2015 | 153.72M |
| September 30, 2015 | 173.36M |
| June 30, 2015 | 124.04M |
| March 31, 2015 | 131.65M |
| December 31, 2014 | 45.24M |
| September 30, 2014 | 49.11M |
| June 30, 2014 | 55.35M |
| March 31, 2014 | 63.32M |
| December 31, 2013 | 71.75M |
| September 30, 2013 | 29.48M |
| June 30, 2013 | 45.60M |
| March 31, 2013 | 63.35M |
| December 31, 2012 | 83.40M |
| September 30, 2012 | 105.64M |
| June 30, 2012 | 122.38M |
| March 31, 2012 | 140.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.678M
Minimum
Jun 2024
198.28M
Maximum
Mar 2020
86.91M
Average
84.99M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 385.92M |
| Oragenics Inc | 2.710M |
| Cocrystal Pharma Inc | 21.57M |
| Cara Therapeutics Inc | 72.50M |
| Jaguar Health Inc | 61.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.907M |
| Shareholders Equity (Quarterly) | 3.771M |
| Current Ratio | 5.158 |
| Net Debt Paydown Yield | 19.63% |